Effect of a Unani drug in urinary infection.

Not Applicable

Completed

Conditions: Health Condition 1: N390- Urinary tract infection, site notspecified

Registration Number: CTRI/2021/09/036138

Lead Sponsor: Rajiv Gandhi University of Health Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Women diagnosed with clinical features such as

Pusht me Dard, Usr al-bawl(dysuria), Bawl al-Dam (haematuria), Salsal al-Bawl(urgency), Hurqa alBawl(Burning), Taqtir al-Bawl (dribbling).

Clinical features of uncomplicated urinary tract

infection (uUTI) symptom as per UTI Assessment

(UTISA) questionnaire

Exclusion Criteria

Women aged up to 18 years and over 60 years.

Pregnant and lactating women.

Those with complicated UTI such as those associated with pyelonephritis, urolithiasis, diabetes, neurological conditions or urinary tract obstructions.

Women who will be catheterized.

Hypersensitivity to nitrofurantoin and impaired renal function

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in clinical features of urinary tract infection (urinary, frequency, urgency, dysuria or haematuria) assessed by UTISA questionnaireTimepoint: 9-10, 25 and 60 days from baseline

Secondary Outcome Measures

Name	Time	Method
1. Change in Severity (e.g., intensity of pain, urgency, <br/ ><br>frequency and burning) of uncomplicated UTI.67 <br/ ><br>2. Change in quality of life (as estimated by validated <br/ ><br>outcomes measures SF-12). <br/ ><br>3. Morisky Medication Adherence Scale-4 used to <br/ ><br>assess compliance with herbal medicine.Timepoint: 9-10, 25 and 60days from baseline